Ledger.Open graph →

SEC Form D · filed December 27, 2023

Abata Therapeutics, Inc

Offering

—

Sold

$15.3M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

WATERTOWN, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Samantha Singer · WATERTOWN, MAExec · Director John Trzupek · WATERTOWN, MAExec Mitch Finer · WATERTOWN, MADirector David Kaufman · New York, NYDirector Leonard Dragone · WATERTOWN, MAExec Valerie Odegard · CAMBRIDGE, MADirector Stephen Sofen · CAMBRIDGE, MAExec Sandy Lazzari · CAMBRIDGE, MAExec Shelley Chu · San Diego, CADirector Nagesh Mahanthappa · Cambridge, MADirector Abbie Celniker · Boston, MADirector Lorence Kim · Cambridge, MADirector Ellen Cahir-Mcfarland · WATERTOWN, MAExec Samantha Singer · Cambridge, MAExec · Director Leonard Dragone · WATERTOWN, MAExec Valerie Odegard · CAMBRIDGE, MADirector Stephen Sofen · CAMBRIDGE, MAExec Sandy Lazzari · CAMBRIDGE, MAExec Shelley Chu · San Diego, CADirector Nagesh Mahanthappa · Cambridge, MADirector John Trzupek · WATERTOWN, MAExec Abbie Celniker · Boston, MADirector Mitch Finer · WATERTOWN, MADirector David Kaufman · Virginai Beach, VADirector Lorence Kim · Cambridge, MADirector Ellen Cahir-Mcfarland · WATERTOWN, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗